U.S. market Closed. Opens in 16 hours 54 minutes

UPC | Universe Pharmaceuticals INC Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.4600 - 0.5424
52 Week Range 0.3810 - 4.32
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 4,191,282
Average Volume 1,961,945
Shares Outstanding 23,646,000
Market Cap 10,877,160
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 2021-03-23
Valuation
Profitability
Growth
Health
P/E Ratio -0.27
Forward P/E Ratio N/A
EPS -1.70
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 225
Country China
Website UPC
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
*Chart delayed
Analyzing fundamentals for UPC we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is unacceptably poor, Growth is on medium level and Health is strong. For more detailed analysis please see UPC Fundamentals page.

Watching at UPC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on UPC Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙